 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Pronota Validates Pre-Eclampsia Markers; Plans Clinical Study to Support 510(k) Submission
July 13, 2012
Pronota Validates Pre-Eclampsia Markers; Plans Clinical Study to Support 510(k) Submission
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Pronota Raises $4.9M to Support Protein Biomarker Validation Studies; Appoints New CEO, Board Member
January 30, 2012 / ProteoMonitor - Pronota Signs Agreement with Molecuence to Develop Protein Biomarkers for Stroke
February 25, 2011 / ProteoMonitor - EU Awards $7.6M to Project Aiding Pronota in Validation of Preeclampsia Test
November 9, 2012 / ProteoMonitor - CPTAC Organizers, Researchers Offer Update on Plans and Progress as Project Data Portal Goes Live
September 21, 2012 / ProteoMonitor - ETH Zurich, ISB Teams Build SRM-MS Assay Library for 1,000-Plus Cancer-Related Proteins
July 13, 2012 / ProteoMonitor